Trial Details
TERMINATEDBasic Information
| Clinical ID | c1420 |
|---|---|
| Identifier | NCT05068284 |
| Trial Title | A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: ABBV-154|DRUG: Placebo|DRUG: ABBV-154|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-01-31 |
|---|---|
| Primary Completion Date | 2023-07-20 |
| Completion Date | 2023-07-20 |